Tower Research Capital LLC (TRC) - VINCERX PHARMA INC ownership

VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 36 filers reported holding VINCERX PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of VINCERX PHARMA INC
ValueSharesWeighting
Q3 2023$7,250
+33.7%
7,178
+72.1%
0.00%
Q2 2023$5,423
+180666.7%
4,172
+41.4%
0.00%
Q1 2023$30.0%2,950
+10.9%
0.00%
Q4 2022$32,661
+6235.7%
0.00%
Q3 2022$0
-100.0%
42
-99.4%
0.00%
Q2 2022$9,000
-10.0%
6,758
+174.0%
0.00%
Q1 2022$10,000
-16.7%
2,466
+106.7%
0.00%
Q4 2021$12,000
+20.0%
1,193
+93.4%
0.00%
Q3 2021$10,000617
+1769.7%
0.00%
Q2 2021$0
-100.0%
33
-80.4%
0.00%
Q1 2021$3,0001680.00%
Other shareholders
VINCERX PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
SAGE RHINO CAPITAL LLC 1,703,413$1,720,4470.48%
Tejara Capital Ltd 233,348$235,6810.13%
KINGDON CAPITAL MANAGEMENT, L.L.C. 385,000$388,8500.04%
SABBY MANAGEMENT, LLC 57,353$57,9270.04%
Long Focus Capital Management, LLC 1,098,753$1,109,7410.04%
Sio Capital Management, LLC 102,049$103,0690.03%
Rock Springs Capital Management LP 891,719$900,6360.02%
Rubric Capital Management LP 354,377$357,9210.01%
Clearline Capital LP 98,916$99,9050.01%
ExodusPoint Capital Management, LP 389,512$3930.00%
View complete list of VINCERX PHARMA INC shareholders